Secondary |
Hypertension |
32.1% |
Ischaemic Heart Disease Prophylaxis |
7.4% |
Renal Failure Chronic |
4.9% |
Stress Urinary Incontinence |
4.9% |
Type 2 Diabetes Mellitus |
4.9% |
Vascular Dementia |
4.9% |
Cardiac Failure Chronic |
3.7% |
Extrapyramidal Disorder |
3.7% |
Initial Insomnia |
3.7% |
Osteoporosis |
3.7% |
Prophylaxis Against Gastrointestinal Ulcer |
3.7% |
Anaemia Of Chronic Disease |
2.5% |
Angina Pectoris |
2.5% |
Atrial Fibrillation |
2.5% |
Gastric Ulcer |
2.5% |
Hyperlipidaemia |
2.5% |
Iron Deficiency |
2.5% |
Oedema |
2.5% |
Restless Legs Syndrome |
2.5% |
Thrombosis Prophylaxis |
2.5% |
|
Renal Failure Acute |
33.3% |
Fallot's Tetralogy |
20.0% |
Ventricular Fibrillation |
13.3% |
Vertigo |
13.3% |
Cardiac Failure |
6.7% |
Hyponatraemia |
6.7% |
Vomiting |
6.7% |
|
Concomitant |
Product Used For Unknown Indication |
50.1% |
Drug Use For Unknown Indication |
17.0% |
Hypertension |
4.2% |
Cardiac Failure |
3.6% |
Rheumatoid Arthritis |
2.5% |
Type 2 Diabetes Mellitus |
2.2% |
Atrial Fibrillation |
2.0% |
Chronic Obstructive Pulmonary Disease |
2.0% |
Coronary Artery Disease |
1.9% |
Parkinson's Disease |
1.9% |
Metastatic Malignant Melanoma |
1.5% |
Non-small Cell Lung Cancer |
1.5% |
Diabetes Mellitus |
1.4% |
Osteoporosis |
1.4% |
Pain |
1.4% |
Ascites |
1.2% |
Breast Cancer |
1.2% |
Depression |
1.2% |
Benign Prostatic Hyperplasia |
1.0% |
Renal Transplant |
1.0% |
|
Death |
10.0% |
General Physical Health Deterioration |
10.0% |
Hallucination |
7.1% |
Pericardial Haemorrhage |
7.1% |
Sepsis |
7.1% |
Pleural Effusion |
5.7% |
Rhabdomyolysis |
5.7% |
Acute Myocardial Infarction |
4.3% |
Haemoglobin Decreased |
4.3% |
Hepatitis |
4.3% |
Off Label Use |
4.3% |
Prostate Cancer |
4.3% |
Pulmonary Embolism |
4.3% |
Urinary Tract Infection |
4.3% |
Blood Creatinine Increased |
2.9% |
Bradycardia |
2.9% |
Bursitis |
2.9% |
Coronary Artery Disease |
2.9% |
Dialysis |
2.9% |
Gastrointestinal Haemorrhage |
2.9% |
|
Interacting |
Hypertension |
26.9% |
Ischaemic Heart Disease Prophylaxis |
15.4% |
Product Used For Unknown Indication |
11.5% |
Extrapyramidal Disorder |
7.7% |
Initial Insomnia |
7.7% |
Prophylaxis Against Gastrointestinal Ulcer |
7.7% |
Stress Urinary Incontinence |
7.7% |
Vascular Dementia |
7.7% |
Pruritus |
3.8% |
Urinary Tract Infection |
3.8% |
|
Renal Failure Acute |
100.0% |
|